NAMA
Nikko Asset Management Americas’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
9,218,455
-346,876
| -4% | -$427K | 0.11% | 87 |
|
|
2025
Q1 | $11.2M | Sell |
9,565,331
-613,170
| -6% | -$717K | 0.14% | 82 |
|
|
2024
Q4 | $18.4M | Sell |
10,178,501
-1,687,265
| -14% | -$3.05M | 0.2% | 72 |
|
|
2024
Q3 | $20.1M | Sell |
11,865,766
-774,795
| -6% | -$1.31M | 0.23% | 67 |
|
|
2024
Q2 | $17.2M | Sell |
12,640,561
-183,824
| -1% | -$250K | 0.2% | 71 |
|
|
2024
Q1 | $48M | Sell |
12,824,385
-375,990
| -3% | -$1.41M | 0.48% | 49 |
|
|
2023
Q4 | $130M | Sell |
13,200,375
-247,291
| -2% | -$2.43M | 1.25% | 22 |
|
|
2023
Q3 | $112M | Sell |
13,447,666
-202,282
| -1% | -$1.69M | 1.34% | 21 |
|
|
2023
Q2 | $181M | Sell |
13,649,948
-356,567
| -3% | -$4.74M | 1.91% | 16 |
|
|
2023
Q1 | $159M | Sell |
14,006,515
-159,678
| -1% | -$1.82M | 1.84% | 18 |
|
|
2022
Q4 | $116M | Sell |
14,166,193
-225,769
| -2% | -$1.84M | 1.67% | 19 |
|
|
2022
Q3 | $84.5M | Buy |
14,391,962
+46,477
| +0.3% | +$273K | 1.08% | 24 |
|
|
2022
Q2 | $61M | Buy |
14,345,485
+324,280
| +2% | +$1.38M | 0.75% | 30 |
|
|
2022
Q1 | $128M | Buy |
14,021,205
+2,106,180
| +18% | +$19.2M | 0.94% | 25 |
|
|
2021
Q4 | $245M | Buy |
11,915,025
+2,567,023
| +27% | +$52.8M | 1.29% | 24 |
|
|
2021
Q3 | $236M | Buy |
9,348,002
+1,225,930
| +15% | +$31M | 1.01% | 28 |
|
|
2021
Q2 | $284M | Buy |
8,122,072
+2,874,835
| +55% | +$101M | 1.11% | 30 |
|
|
2021
Q1 | $175M | Buy |
5,247,237
+228,099
| +5% | +$7.6M | 0.86% | 38 |
|
|
2020
Q4 | $130M | Buy |
5,019,138
+902,585
| +22% | +$23.4M | 0.74% | 45 |
|
|
2020
Q3 | $41.2M | Buy |
+4,116,553
| New | +$41.2M | 0.37% | 59 |
|
|
2018
Q4 | – | Sell |
-6,478
| Closed | -$36K | – | 150 |
|
|
2018
Q3 | $36K | Buy |
+6,478
| New | +$36K | ﹤0.01% | 140 |
|